prof. dr hab. Piotr Popik

prof. dr hab. Piotr Popik

+48 12 6623375
pokój 30
Zakład Badań Nowych Leków

Dokonania naukowe

  • Publikacje

Novel NMDA receptor antagonist neramexane, enhances antidepressant-like effects of imipramine but not imipramine-induced increase in BDNF expression

Autorzy: Piotr Popik

DOI:
Date: 2006-01-01

Nicotine potentiates imipramine-induced effects on catecholamine metabolism: Possible relation to antidepressant activity

Autorzy: Antkiewicz-Michaluk, L., Michaluk, J., Romańska, I., Popik, P., Krawczyk, M., Nalepa, I., Vetulani, J.

DOI:
Date: 2006-01-01

The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]- pyrimidin-3-yl(pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at α1 subunit-containing GABAA receptors

Autorzy: Popik, P., Kostakis, E., Krawczyk, M., Nowak, G., Szewczyk, B., Krieter, P., Chen, Z., Russek, S.J., Gibbs, T.T., Farb, D.H., Skolnick, P., Lippa, A.S., Basile, A.S.

DOI: 10.1124/jpet.106.107201
Date: 2006-01-01

Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice

Autorzy: Kos, T., Legutko, B., Danysz, W., Samoriski, G., Popik, P.

DOI: 10.1124/jpet.106.103697
Date: 2006-01-01

Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677

Autorzy: Popik, P., Krawczyk, M., Golembiowska, K., Nowak, G., Janowsky, A., Skolnick, P., Lippa, A., Basile, A.S.

DOI: 10.1007/s10571-006-9012-5
Date: 2006-01-01

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

Autorzy: Skolnick, P., Krieter, P., Tizzano, J., Basile, A., Popik, P., Czobor, P., Lippa, A.

DOI: 10.1111/j.1527-3458.2006.00123.x
Date: 2006-01-01

Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice

Autorzy: Kos, T., Popik, P., Pietraszek, M., Schäfer, D., Danysz, W., Dravolina, O., Blokhina, E., Galankin, T., Bespalov, A.Y.

DOI: 10.1016/j.euroneuro.2005.10.001
Date: 2006-01-01

Reinstatement of morphine-conditioned reward is blocked by memantine

Autorzy: Popik, P., Wrobel, M., Bisaga, A.

DOI: 10.1038/sj.npp.1300760
Date: 2006-01-01

Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance

Autorzy: Danysz, W., Kozela, E., Parsons, C.G., Sladek, M., Bauer, T., Popik, P.

DOI: 10.1016/j.neuropharm.2004.11.005
Date: 2005-01-01

2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice

Autorzy: Kozela, E., Wrobel, M., Kos, T., Wojcikowski, J., Daniel, W.A., Wozniak, K.M., Slusher, B.S., Popik, P.

DOI: 10.1007/s00213-005-0182-5
Date: 2005-01-01

Zobacz także